Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 36% ± 15% | |
peripheral blood | 18 studies | 36% ± 20% | |
brain | 14 studies | 34% ± 15% | |
intestine | 10 studies | 35% ± 15% | |
eye | 10 studies | 39% ± 19% | |
kidney | 9 studies | 32% ± 13% | |
lymph node | 6 studies | 26% ± 6% | |
liver | 6 studies | 48% ± 17% | |
bone marrow | 5 studies | 33% ± 19% | |
heart | 5 studies | 32% ± 5% | |
uterus | 5 studies | 49% ± 11% | |
adipose | 5 studies | 38% ± 20% | |
breast | 5 studies | 38% ± 14% | |
pancreas | 4 studies | 35% ± 19% | |
prostate | 4 studies | 28% ± 4% | |
placenta | 3 studies | 26% ± 1% | |
esophagus | 3 studies | 40% ± 25% | |
stomach | 3 studies | 35% ± 24% | |
thymus | 3 studies | 48% ± 16% | |
skin | 3 studies | 46% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 20920.48 | 21 / 21 | 100% | 95.18 | 504 / 504 |
esophagus | 100% | 19867.00 | 1445 / 1445 | 100% | 79.01 | 183 / 183 |
intestine | 100% | 23937.64 | 966 / 966 | 100% | 85.62 | 527 / 527 |
uterus | 100% | 26447.24 | 170 / 170 | 100% | 121.81 | 459 / 459 |
breast | 100% | 24488.51 | 459 / 459 | 100% | 110.93 | 1117 / 1118 |
lung | 100% | 26432.55 | 578 / 578 | 100% | 99.03 | 1153 / 1155 |
prostate | 100% | 25199.08 | 245 / 245 | 100% | 82.80 | 500 / 502 |
ovary | 100% | 30063.24 | 180 / 180 | 100% | 68.84 | 428 / 430 |
thymus | 100% | 31647.62 | 653 / 653 | 100% | 104.54 | 602 / 605 |
stomach | 100% | 18771.70 | 359 / 359 | 99% | 73.68 | 284 / 286 |
pancreas | 100% | 18382.83 | 328 / 328 | 99% | 88.76 | 176 / 178 |
skin | 100% | 21773.26 | 1809 / 1809 | 98% | 85.31 | 461 / 472 |
kidney | 100% | 19570.92 | 89 / 89 | 97% | 84.69 | 874 / 901 |
brain | 97% | 9575.12 | 2554 / 2642 | 100% | 101.19 | 705 / 705 |
adrenal gland | 100% | 21843.32 | 258 / 258 | 96% | 58.90 | 221 / 230 |
liver | 100% | 15011.59 | 226 / 226 | 96% | 50.85 | 388 / 406 |
adipose | 100% | 22277.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 19152.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 122.68 | 29 / 29 |
spleen | 100% | 38069.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 109.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.62 | 1 / 1 |
muscle | 100% | 10076.44 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 11114.95 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 11207.43 | 748 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 35.84 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0006396 | Biological process | RNA processing |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0008266 | Molecular function | poly(U) RNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HNRNPH1 |
Protein name | Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed] Heterogeneous nuclear ribonucleoprotein H1 |
Synonyms | HNRPH HNRPH1 |
Description | FUNCTION: This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation. Inhibits, together with CUGBP1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds poly(RG). . |
Accessions | A0A9L9PY23 H0YBD7 ENST00000504348.5 ENST00000523137.6 E5RGV0 D6RBM0 ENST00000522256.1 ENST00000710500.1 ENST00000504779.6 ENST00000512273.5 ENST00000710511.1 E9PCY7 H0YBW2 ENST00000513225.6 D6RDU3 ENST00000505811.5 H0YB39 ENST00000515714.6 D6RAM1 ENST00000510678.6 D6RIT2 ENST00000356731.9 ENST00000710515.1 ENST00000393432.9 H0YBK1 ENST00000515158.5 ENST00000515714.5 G8JLB6 ENST00000710513.1 ENST00000506721.6 ENST00000710512.1 D6RIU0 ENST00000442819.6 ENST00000508103.6 ENST00000521116.5 ENST00000503105.5 ENST00000523449.5 ENST00000710510.1 ENST00000638505.3 E5RJ94 ENST00000503664.1 D6R9D3 ENST00000523136.1 D6RDL0 ENST00000521173.6 ENST00000519958.5 ENST00000505811.6 ENST00000710502.1 E7EN40 ENST00000519056.5 ENST00000329433.11 ENST00000510431.6 H0YAQ2 ENST00000521116.6 D6RFM3 D6RF17 E7EQJ0 P31943 ENST00000515158.6 ENST00000510411.6 ENST00000706924.1 ENST00000513225.5 ENST00000523921.2 |